Barinthus Biotherapeutics Plc.
Earnings Surprise
Analysts estimated BRNS earnings of $-0.35 per share this quarter (Q4). BRNS's actual earnings were $-0.27 per share.
BRNS EPS surprise of 23.27%Analysts estimated BRNS earnings of $-0.46 per share this quarter (Q3). BRNS's actual earnings were $-0.24 per share.
BRNS EPS surprise of 47.71%Analysts estimated BRNS earnings of $-0.34 per share this quarter (Q2). BRNS's actual earnings were $-0.52 per share.
BRNS EPS surprise of -54.49%Analysts estimated BRNS earnings of $-0.34 per share this quarter (Q1). BRNS's actual earnings were $-0.49 per share.
BRNS EPS surprise of -43.40%Analysts estimated BRNS earnings of $-0.42 per share this quarter (Q4). BRNS's actual earnings were $-0.51 per share.
BRNS EPS surprise of -20.97%Analysts estimated BRNS earnings of $-0.45 per share this quarter (Q3). BRNS's actual earnings were $-0.21 per share.
BRNS EPS surprise of 53.56%Analysts estimated BRNS earnings of $-0.55 per share this quarter (Q1). BRNS's actual earnings were $-0.40 per share.
BRNS EPS surprise of 27.91%Analysts estimated BRNS earnings of $-0.51 per share this quarter (Q4). BRNS's actual earnings were $-0.45 per share.
BRNS EPS surprise of -11.66%Analysts estimated BRNS earnings of $-0.54 per share this quarter (Q3). BRNS's actual earnings were $-0.37 per share.
BRNS EPS surprise of -31.56%